Efficacy of Hydroxyurea (HU) in Reduction of Pack Red Cell (PRC) Transfusion Requirement Among Children Having Beta-thalassemia Major: Karachi HU Trial (KHUT)

HU was found to be safe in patients with beta-thalassemia major, and resulted in reduction in the transfusion requirements and in increase of the intervals between transfusions.